Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Cyanotech Corporation(CYAN)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for CYAN
09/14/2026: CYAN (1-star) is currently NOT-A-BUY. Pass it for now.
Cyanotech Corporation is a small-cap biotechnology company specializing in the production of microalgae-based supplements like BioAstin and Hawaiian Spirulina. The company possesses a strong brand identity and a unique, Hawaii-based production facility, which serves as a core competitive advantage. Its primary growth opportunity lies in leveraging direct-to-consumer sales channels to improve margins. However, the company faces significant risks, including intense price competition from larger global producers, historical financial instability, and operational execution challenges. As a non-dividend-paying stock with high volatility, it is generally best suited for investors with a high risk tolerance who are willing to monitor ongoing operational efficiency and brand expansion developments closely.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | The company has struggled to maintain consistent revenue growth and lacks a clear, high-velocity expansion strategy. |
| Momentum investor | Weak fit | The stock often lacks the strong, sustained price trend required for momentum strategies. |
| Value investor | Mixed fit | The company may appear inexpensive, but the valuation is often justified by underlying operational risks. |
| Dividend investor | Weak fit | The company does not pay dividends and has not demonstrated the cash flow stability to initiate one. |
| Low-risk investor | Weak fit | High operational volatility and financial performance risks make this unsuitable for low-risk portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock price is subject to large swings based on operational updates and market sentiment. |
| Valuation risk | Medium | Difficulty in predicting future cash flows complicates valuation models. |
| Competition risk (nutraceutical/algae) | High | Intense competition from low-cost providers erodes potential profit margins. |
| Business quality | Medium | Consistent profitability is a recurring challenge that impacts business sustainability. |
| Dividend income | Low / none | Investors should not expect income generation from this equity. |
| Execution risk | High | Operational success depends heavily on complex, site-specific biological cultivation. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -84.2% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/14/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 3.52M USD | Price to earnings Ratio - | 1Y Target Price 14 |
Price to earnings Ratio - | 1Y Target Price 14 | ||
Volume (30-day avg) 3.7K shares | Beta 0.08 | 52 Weeks Range 0.23 - 0.57 | Updated Date 09/14/2026 |
52 Weeks Range 0.23 - 0.57 | Updated Date 09/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.24 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Natural Products (Finished Goods) | BioAstin and Hawaiian Spirulina products sold via e-commerce and retail. | The company sells branded supplements directly to health-conscious consumers. |
| Bulk Ingredients | Supplying microalgae raw materials to other companies. | Cyanotech acts as a wholesale supplier for other supplement brands. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 14.79 | Enterprise Value 14.84M | Price to Sales(TTM) 0.14 |
Enterprise Value 14.84M | Price to Sales(TTM) 0.14 | ||
Enterprise Value to Revenue 0.59 | Enterprise Value to EBITDA 21.94 | Shares Outstanding 7.25M | Shares Floating 4.85M |
Shares Outstanding 7.25M | Shares Floating 4.85M | ||
Percent Insiders 32.77 | Percent Institutions - |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Cyanotech Corporation
Exchange NASDAQ | Headquarters Kailua-Kona, HI, United States | ||
IPO Launch date 1993-06-22 | President, CEO & Director Mr. Matthew Keith Custer | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 83 | Website https://www.cyanotech.com |
Full time employees 83 | Website https://www.cyanotech.com | ||
Cyanotech Corporation, an agricultural company, engages in the production and sale of natural ingredients and dietary supplement products from microalgae for health and wellness markets. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction, and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. It operates in the United States, the Asia-Pacific, Europe, and internationally. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.